What is the trade name of fondaparinux?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Trade Name for Fondaparinux

Fondaparinux is marketed under the trade name Arixtra. 1

Key Product Information

  • Generic name: Fondaparinux sodium 2, 3
  • Brand name: Arixtra 1, 2
  • Manufacturer: Sanofi-Synthelabo (now part of Sanofi) 4
  • Drug class: Synthetic pentasaccharide, selective factor Xa inhibitor 5, 2, 4

Clinical Context

Arixtra (fondaparinux) is FDA-approved for:

  • Prophylaxis of venous thromboembolism (VTE) following major orthopedic surgery 6, 2
  • Treatment of acute deep vein thrombosis and pulmonary embolism 5, 7
  • Treatment of acute coronary syndromes (in combination with other therapies) 8

The medication is administered as a once-daily subcutaneous injection due to its 17-21 hour half-life, which distinguishes it from low-molecular-weight heparins that often require twice-daily dosing. 5, 3

References

2
Research

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.

Expert opinion on pharmacotherapy, 2004

4
Research

Fondaparinux, the first selective factor Xa inhibitor.

Current opinion in hematology, 2003

6
Guideline

venous thromboembolic disease.

Journal of the National Comprehensive Cancer Network : JNCCN, 2011

7
Research

Fondaparinux: an update on new study results.

European journal of clinical investigation, 2005

Related Questions

What is fondaparinux?
What is the therapeutic dose of fondaparinux (a low molecular weight heparin) for anticoagulation?
How is fondaparinux (a low molecular weight anticoagulant) metabolized?
What is the recommended dosing, contraindications, and monitoring for using fondaparinux (Arixtra) to treat acute pulmonary embolism in adults?
Is fondaparinux (a selective Factor Xa inhibitor) first-line indicated for any conditions?
What is the appropriate management for a stage 4 pressure ulcer over the coccyx with foul odor?
What medium‑potency topical corticosteroid, dosing schedule, and duration should be used for a limited mild‑to‑moderate inflammatory skin rash that has not responded to a low‑potency steroid on non‑facial, non‑intertriginous skin?
Can I increase sertraline (Zoloft) from 25 mg to 50 mg daily for a patient with anxiety after two weeks of therapy?
What could cause severe pain, limited flexion and extension, and palpable nodules in my fingers that prevent me from fully opening and closing my hands or gripping a utensil, and how should I manage it?
What does a ground‑glass opacity (GGO) on a chest X‑ray indicate and how should it be evaluated and managed?
Should a hemodynamically stable patient with a 1.1 cm kidney stone and no signs of infection or uncontrolled pain be sent to the emergency department?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.